Key facts
- It has raised $3.0M; the latest was Later Stage VC in Jan 2026.
- Notable investors include MassChallenge, Pitango Venture Capital, Fresh.Fund, Springbank Collective, Bertelsmann Investments — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Guardoc
- ·The full record, as it builds
Funding rounds
No funding rounds for Guardoc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guardoc
Developer of a clinical risk management platform intended to eliminate documentation errors and reduce wasted nursing hours. The company's platform integrates with the organization's electronic healthcare record to identify the mistakes, gaps, and discrepancies in clinical charting within the critical time frame for correction, enabling hospitals to meet regulations, enhance patient care, and optimize revenue management.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 25
- Website
- guardoc.health/
- Ownership
- Privately Held (backing)
Guardoc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guardoc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guardoc in its N-PORT filings yet. We sweep new filings monthly.